No Result
View All Result
SUBMIT YOUR ARTICLES
  • Login
Wednesday, October 29, 2025
TheAdviserMagazine.com
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
No Result
View All Result
TheAdviserMagazine.com
No Result
View All Result
Home Market Research Business

Why Kymera (KYMR) Could Be One of Biotech’s Most Interesting Growth Stories?

by TheAdviserMagazine
2 months ago
in Business
Reading Time: 2 mins read
A A
Why Kymera (KYMR) Could Be One of Biotech’s Most Interesting Growth Stories?
Share on FacebookShare on TwitterShare on LInkedIn


Kymera Therapeutics Inc. (NASDAQ:KYMR) is one of the best high-beta stocks to buy now. The company currently commands an optimistic outlook, with management remaining confident in achieving key clinical endpoints and biomarker data.

This confidence was visible on September 3, when the company presented at Citi’s ‘Biopharma Back to School’ Conference and outlined the progress across its targeted protein degradation (TPD) platform. Kymera Therapeutics Inc. (NASDAQ:KYMR) highlighted pipeline updates, with its lead asset, KT-4621, advancing into Phase 2 trials for atopic dermatitis and asthma.

For context, targeted protein degradation (TPD) is a therapeutic approach that uses the body’s own protein disposal system to find and break down harmful proteins that cause disease. Unlike traditional inhibitors, which block activity but leave the protein intact, TPD therapies remove the protein entirely, which makes treatments more effective and longer-lasting.

Why Kymera (KYMR) Could Be One of Biotech’s Most Interesting Growth Stories

Pressmaster/Shutterstock.com

Early Phase 1b data in atopic dermatitis patients is expected later this year, and two Phase 2b trials, one in dermatitis and one in asthma, are scheduled to begin in late 2025 and 2026, respectively. Management is also preparing Phase III manufacturing for KT-4621, to ensure scalability at a lower cost.

Kymera Therapeutics Inc. (NASDAQ:KYMR) is developing oral TPD drugs that could provide greater accessibility and convenience as compared to injectable options. The company is advancing a broad pipeline and working with partners such as Sanofi to move its programs through clinical trials, though regulatory approvals remain an important factor.

The company is a consensus Buy, with all analysts covering it assigning a Buy or equivalent rating. The latest one to assert a bullish view was Brian Cheng from JP Morgan, who reaffirmed a Buy rating on August 21 with a price target of $64, implying over 55% potential upside.

Kymera Therapeutics Inc. (NASDAQ:KYMR) is a clinical-stage biopharmaceutical company developing protein degradation therapies for immune and inflammatory diseases and cancer.

While we acknowledge the potential of KYMR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 12 Overlooked Large-Cap Stocks with Low Multiples and 10 Best Stocks for a 20 Year Long-Term Stock Portfolio.

Disclosure: None. This article is originally published at Insider Monkey.



Source link

Tags: BiotechsgrowthInterestingKymeraKYMRstories
ShareTweetShare
Previous Post

I’m a new mom and my aunt gifted me $55K — but I can’t tell anyone. How do I spend this covert cash wisely?

Next Post

We Have Never Been Woke, Part 10: Should We Be Woke?

Related Posts

edit post
Asian stocks: Asian stocks open higher as AI, Fed lift sentiment

Asian stocks: Asian stocks open higher as AI, Fed lift sentiment

by TheAdviserMagazine
October 28, 2025
0

Asian stocks opened higher, buoyed by Wall Street optimism that artificial intelligence will keep fueling profits at major technology firms...

edit post
OrthoPediatrics outlines path to 12% baseline growth and free cash flow breakeven by 2026 amid clinic expansion and strong T&D momentum (NASDAQ:KIDS)

OrthoPediatrics outlines path to 12% baseline growth and free cash flow breakeven by 2026 amid clinic expansion and strong T&D momentum (NASDAQ:KIDS)

by TheAdviserMagazine
October 28, 2025
0

Seeking Alpha's Disclaimer: The earnings call insights are compilations of earnings call transcripts and other content available on the Seeking...

edit post
A major ICE shake-up is reportedly underway affecting at least half of the agency’s top leadership positions

A major ICE shake-up is reportedly underway affecting at least half of the agency’s top leadership positions

by TheAdviserMagazine
October 28, 2025
0

WASHINGTON (AP) — The Trump administration is reassigning at least half the top leadership at Immigration and Customs Enforcement offices...

edit post
Saudi power chair: Tariffs weaken the global energy transition and hurt humanity

Saudi power chair: Tariffs weaken the global energy transition and hurt humanity

by TheAdviserMagazine
October 28, 2025
0

The global energy transition continues to press forward, but tariff wars and the rising politicization of renewable power is hurting...

edit post
Judge extends order barring Trump administration from firing federal workers during shutdown

Judge extends order barring Trump administration from firing federal workers during shutdown

by TheAdviserMagazine
October 28, 2025
0

A federal judge in San Francisco on Tuesday indefinitely barred the Trump administration from firing federal employees during the government...

edit post
Wizz Air uncompromising on demands for Israel hub

Wizz Air uncompromising on demands for Israel hub

by TheAdviserMagazine
October 28, 2025
0

Senior officials from Israel’s Ministry of Transport have traveled to Hungary for intensive talks with top Wizz Air executives...

Next Post
edit post
We Have Never Been Woke, Part 10: Should We Be Woke?

We Have Never Been Woke, Part 10: Should We Be Woke?

edit post
1 Incredible Reason to Buy This Dividend Stock Before Oct. 14

1 Incredible Reason to Buy This Dividend Stock Before Oct. 14

  • Trending
  • Comments
  • Latest
edit post
77-year-old popular furniture retailer closes store locations

77-year-old popular furniture retailer closes store locations

October 18, 2025
edit post
Pennsylvania House of Representatives Rejects Update to Child Custody Laws

Pennsylvania House of Representatives Rejects Update to Child Custody Laws

October 7, 2025
edit post
What to Do When a Loved One Dies in North Carolina

What to Do When a Loved One Dies in North Carolina

October 8, 2025
edit post
Another Violent Outburst – Democrats Inciting Civil Unrest

Another Violent Outburst – Democrats Inciting Civil Unrest

October 24, 2025
edit post
Probate vs. Non-Probate Assets: What’s the Difference?

Probate vs. Non-Probate Assets: What’s the Difference?

October 17, 2025
edit post
California Attorney Pleads Guilty For Role In 2M Ponzi Scheme

California Attorney Pleads Guilty For Role In $912M Ponzi Scheme

October 15, 2025
edit post
Check Point Q3 profit jumps 73.4% due to tax settlement

Check Point Q3 profit jumps 73.4% due to tax settlement

0
edit post
Fifth Circuit Expands Tire Import Excise Tax – Houston Tax Attorneys

Fifth Circuit Expands Tire Import Excise Tax – Houston Tax Attorneys

0
edit post
This San Francisco-based satellite company’s stock has doubled in the past three months

This San Francisco-based satellite company’s stock has doubled in the past three months

0
edit post
The U.S. LNG Boom Could Make Energy More Expensive for Americans

The U.S. LNG Boom Could Make Energy More Expensive for Americans

0
edit post
Trump says he expects to lower fentanyl-related tariffs on Beijing, discuss ‘farmers’

Trump says he expects to lower fentanyl-related tariffs on Beijing, discuss ‘farmers’

0
edit post
Trump Insider Whale Reloads 0M Long on BTC, ETH Ahead of Tomorrow’s Fed Rate Cut Decision

Trump Insider Whale Reloads $430M Long on BTC, ETH Ahead of Tomorrow’s Fed Rate Cut Decision

0
edit post
Trump says he expects to lower fentanyl-related tariffs on Beijing, discuss ‘farmers’

Trump says he expects to lower fentanyl-related tariffs on Beijing, discuss ‘farmers’

October 28, 2025
edit post
Asian stocks: Asian stocks open higher as AI, Fed lift sentiment

Asian stocks: Asian stocks open higher as AI, Fed lift sentiment

October 28, 2025
edit post
OrthoPediatrics outlines path to 12% baseline growth and free cash flow breakeven by 2026 amid clinic expansion and strong T&D momentum (NASDAQ:KIDS)

OrthoPediatrics outlines path to 12% baseline growth and free cash flow breakeven by 2026 amid clinic expansion and strong T&D momentum (NASDAQ:KIDS)

October 28, 2025
edit post
Most Popular Halloween Candy of 2025: What Trick-Or-Treaters Really Want

Most Popular Halloween Candy of 2025: What Trick-Or-Treaters Really Want

October 28, 2025
edit post
Inside CampusAI’s mission to close the AI training gap for everyday workers — check it out at TechCrunch Disrupt 2025

Inside CampusAI’s mission to close the AI training gap for everyday workers — check it out at TechCrunch Disrupt 2025

October 28, 2025
edit post
Advisors still in ‘collective dabbler’ stage of AI adoption

Advisors still in ‘collective dabbler’ stage of AI adoption

October 28, 2025
The Adviser Magazine

The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.

CATEGORIES

  • 401k Plans
  • Business
  • College
  • Cryptocurrency
  • Economy
  • Estate Plans
  • Financial Planning
  • Investing
  • IRS & Taxes
  • Legal
  • Market Analysis
  • Markets
  • Medicare
  • Money
  • Personal Finance
  • Social Security
  • Startups
  • Stock Market
  • Trading

LATEST UPDATES

  • Trump says he expects to lower fentanyl-related tariffs on Beijing, discuss ‘farmers’
  • Asian stocks: Asian stocks open higher as AI, Fed lift sentiment
  • OrthoPediatrics outlines path to 12% baseline growth and free cash flow breakeven by 2026 amid clinic expansion and strong T&D momentum (NASDAQ:KIDS)
  • Our Great Privacy Policy
  • Terms of Use, Legal Notices & Disclosures
  • Contact us
  • About Us

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.